Chris Degnan's Net Worth

-$58.2 Thousand

Estimate Recalculated Nov 7, 2024 12:15PM EST

Who is Chris Degnan?

Chris Degnan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verrica Pharmaceuticals Inc., and Galera Therapeutics, Inc..

SEC CIK

Chris Degnan's CIK is 0001741968

Past Insider Trading and Trends

2019 was Chris Degnan's most active year for acquiring shares with 2 total transactions. Chris Degnan's most active month to acquire stocks was the month of January. 2018 saw Chris Degnan paying a total of $45,000.00 for 3,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Verrica Pharmaceuticals Inc. (VRCA) Snapshot price: $1.9099

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 28
Form 4
∞
3K
$15.00
$45,000.00
3K
Jun 19
Form 3
—
0
—
—
0
No matching records found

Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.0644

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
10K
$1.96
$19,593.00
10K
Mar 13
Form 4
—
0
—
—
0
Feb 25
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
Nov 6
Form 3
—
0
—
—
0
No matching records found